Table 2 Thermocoagulation assessment immediately after treatment and at the 1-month control visit
Variable | N | % | ||
|---|---|---|---|---|
Immediately after treatment | Total women treated | 110 | 90.9 | |
Pain | ||||
Yes | 105 | 95.5 | ||
No | 3 | 2.7 | ||
Not specified | 2 | 1.8 | ||
VAS pain score (mean ± SD) | 3.0 ± 1.6 | |||
VAS pain score (median, range) | 2 (1–8) | |||
Desire of future pregnancy | 54 | 49.1 | ||
At the 1-month control visit | Total women seen at the 1-month visit | 109 | 99.1 | |
Pain | ||||
Yes | 34 | 31.2 | ||
No | 75 | 68.8 | ||
VAS pain score (mean ± SD) | 0.8 ± 1.4 | |||
Pain duration (mean ± SD), days | 2.1 ± 4.8 | |||
Vaginal discharge | ||||
Yes | 108 | 99.1 | ||
No | 1 | 0.9 | ||
Vaginal discharge duration (mean ± SD), days | 16.2 ± 8.4 | |||
Cicatrisation | ||||
Yes | 100 | 91.7 | ||
No | 9 | 8.3 |